top of page
Browse by category
Search
![](https://static.wixstatic.com/media/1f382d_23d4bd93c42846b4b095c62bc5ba7003~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,lg_1,q_30,blur_30,enc_auto/1f382d_23d4bd93c42846b4b095c62bc5ba7003~mv2.webp)
![BioAge axes STRIDES trial evaluating azelaprag in combination with tirzepatide for the treatment of obesity](https://static.wixstatic.com/media/1f382d_23d4bd93c42846b4b095c62bc5ba7003~mv2.jpg/v1/fill/w_225,h_207,fp_0.50_0.50,q_90,enc_auto/1f382d_23d4bd93c42846b4b095c62bc5ba7003~mv2.webp)
BioAge axes STRIDES trial evaluating azelaprag in combination with tirzepatide for the treatment of obesity
BioAge Labs is to discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag as monotherapy and in...
Browse by tag
bottom of page